Loading stock data…
Microbot Medical Inc. (MBOT)
$1.50+0.06 (+4.17%)
Market ClosedLast close Sep 8
Microbot Medical Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Microbot Medical Inc. in the Healthcare sector is trading at $1.50 with a market capitalization of $101M. Wall Street consensus targets $6.67 (3 analysts), implying a +344.4% move over the next 12 months. The stock is currently near its 52-week low of $1.44, remaining 26.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +344.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $105,000 | $0 | $0 | $0 | $0 |
| Gross Profit | $2,000 | — | — | — | $0 |
| Operating Income | -$4.32M↓ | -$4.14M↓ | -$3.86M↓ | -$3.72M↓ | -$3.02M |
| Net Income | -$3.67M↓ | -$3.46M↑ | -$3.58M↓ | -$3.50M↓ | -$2.60M |
Peer Comparison
JNJUNHPFE
Fundamentals
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical sy...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$100.75M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.03
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.46%
Volume
Today's trading volume
559,170
Recent News
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
Microbot Medical (MBOT) delivered earnings and revenue surprises of 0.00% and -22.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Why Is Sanmina (SANM) Stock Soaring Today
Shares of electronics manufacturing services company Sanmina (NASDAQ:SANM) jumped 5.4% in the afternoon session after Microbot Medical selected it as a manufacturing partner for its LIBERTY® Endovascular Robotic System.
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?